News
Strong profit potential! The global legal cannabis market is expected to exceed $110 billion, and the cannabis pharmaceuticals market is expected to reach $72.7 billion by 2030.
Global Legal Cannabis Market Size at $33.8 Billion by 2024
Here comes the turning point for the industry! The UK government has created an industrial hemp innovation center.
The new Industrial Hemp Innovation Center will head an important UK parliamentary body, signaling a renewed effort by UK authorities to reform hemp policy and promote industry growth.
A child's life was lost in a tragic accident. The state has officially started to review its medical marijuana policy.
How many years can patients wait from 2021 to 2025?It took four years to go from saying it cannot be used for medical treatment to doubting it, to asking for a constitutional review, to a sick child passing away before research on legalization for medical use is finally announced.
Japan is experiencing a new trend: CBD-infused foods that provide a refreshing experience. The first supplement containing cannabidiol (CBD) that contains no THC has been approved for marketing.
In 2025, we made a big step in the Japanese market when HealthyTOKYO Morning Gummies and Lazarus Energy Capsules, which are Cbd products with 0 THC, were approved. These products are meant to help with mental stimulation. The right mix of low-dose CBD and natural ingredients makes "Calm Wakefulness" work. It can improve your concentration and give you better mental performance without the side effects of traditional products.
USDA Releases Hemp Industry Report: Flowers Dominate, Fiber Hemp Acreage Expands but Revenues Fall, Seed Hemp Performs Steadily
U.S. hanseed acreage reached 45,294 acres in 2024, a 64% increase from 2023, and total value jumped 40% to $445 million.
According to a new study, cannabinoids might be more effective than afatinib for HER2-positive cancers.
Research shows that cannabinoids, especially CBD and CBG, can be used as alternative or supplemental treatments for HER2-positive cancers. These cannabinoids can help reduce resistance to drugs and negative side effects.
What is the state of the German cannabis industry one year after legalization?
Starting this month, all Czech doctors will be able to prescribe medical marijuana for chronic patients. However, monthly reimbursement by health insurance companies is limited.
Starting April 1, 2025, doctors in the Czech Republic will be able to prescribe medical marijuana for patients with chronic pain.
The European Medicines Agency says there is less of the main active ingredient in cannabis in the wastewater samples taken from 128 European cities, but more of another active ingredient, a stimulant.
A new study of wastewater from 128 European cities shows that cannabis use is decreasing while stimulant drug use like cocaine and MDMA (ecstasy) is increasing.
The study looked at samples of wastewater every day from areas where wastewater treatment plants are located. This study was done from March to May of 2024. They looked for five stimulant drugs: amphetamine, cocaine, methamphetamine, MDMA/ecstasy, and ketamine. They also looked for cannabis.
The EU finally spoke out. They made it clear: hemp-derived CBD is not a narcotic, and it is a legitimate ingredient that can be traded freely between member states.
The European Commission recently responded to a request for clarification from the trade press regarding Portugal's National Agency for Medicines and Health Products' (Infarmed's) decision to withdraw several cosmetic products containing cannabidiol (CBD) extracted from the hanseatic plant from the market.
The European Commission's (EC) response introduces a new dimension to the controversy, directly contradicting the position of the Portuguese regulator. The EC made it clear that CBD, whether synthetic or derived from hanseatic hemp, cannot be classified as a narcotic under the Court of Justice of the European Union (CJEU)'s or European regulations' standards. The European Commission also made it clear that it is currently conducting a scientific assessment to determine safety standards for CBD and THC in cosmetics.